>AT1G14830.1 | ADL1C (ARABIDOPSIS DYNAMIN-LIKE PROTEIN 1C) GTP binding / GTPase
MATMKSLIGLINKIQRACTVLGDHGGEGMSLWEALPTVAVVGGQSSGKSSVLESVVGRDF
LPRGSGIVTRRPLVLQLHKTEDGTTEYAEFLHAPKKRFADFAAVRKEIEDETDRITGKSK
QISNIPIQLSIYSPNVVNLTLIDLPGLTKVAVDGQPESIVQDIENMVRSYVEKPNCIILA
ISPANQDIATSDAIKLAREVDPTGERTFGVATKLDIMDKGTDCLDVLEGRSYRLQHPWVG
IVNRSQADINKRVDMIAARRKEQEYFETSPEYGHLASRMGSEYLAKLLSQHLETVIRQKI
PSIVALINKSIDEINAELDRIGRPIAVDSGAQLYTILELCRAFDRVFKEHLDGGRPGGDR
IYGVFDHQLPAALKKLPFDRHLSTKNVQKVVSEADGYQPHLIAPEQGYRRLIDGSISYFK
GPAEATVDAVHFVLKELVRKSISETEELKRFPTLASDIAAAANEALERFRDESRKTVLRL
VDMESSYLTVEFFRKLHLEPEKEKPNPRNAPAPNADPYSDNHFRKIGSNVSAYINMVCDT
LRNSLPKAVVYCQVREAKRSLLNFFYAQVGRKEKEKLGAMLDEDPQLMERRGTLAKRLEL
YKQARDDIDAVAWK*
>AT1G63080.1 | pentatricopeptide (PPR) repeat-containing protein
MSLAKRFVHLRKASPSFCLRGIYFSGLSYDGYREKLSRNALLHLKLDEAVDLFGEMVKSR
PFPSIVEFSKLLSAIAKMKKFDLVISFGEKMEILGVSHNLYTYNIMINCLCRRSQLSFAL
AILGKMMKLGYGPSIVTLNSLLNGFCHGNRISEAVALVDQMVEMGYQPDTVTFTTLVHGL
FQHNKASEAVALVERMVVKGCQPDLVTYGAVINGLCKRGEPDLALNLLNKMEKGKIEADV
VIYSTVIDSLCKYRHVDDALNLFTEMDNKGIRPDVFTYSSLISCLCNYGRWSDASRLLSD
MLERKINPNVVTFNSLIDAFAKEGKLIEAEKLFDEMIQRSIDPNIVTYNSLINGFCMHDR
LDEAQQIFTLMVSKDCLPDVVTYNTLINGFCKAKKVVDGMELFRDMSRRGLVGNTVTYTT
LIHGFFQASDCDNAQMVFKQMVSDGVHPNIMTYNTLLDGLCKNGKLEKAMVVFEYLQKSK
MEPDIYTYNIMSEGMCKAGKVEDGWDLFCSLSLKGVKPDVIAYNTMISGFCKKGLKEEAY
TLFIKMKEDGPLPDSGTYNTLIRAHLRDGDKAASAELIKEMRSCRFAGDASTYGLVTDML
HDGRLDKGFLEVLS*
>AT2G39800.2 | P5CS1 (DELTA1-PYRROLINE-5-CARBOXYLATE SYNTHASE 1) delta1-pyrroline-5-carboxylate synthetase
MAYYETMFDQLDVTAAQLLVNDSSFRDKDFRKQLNETVKSMLDLRVIPIFNENDAISTRR
APYQDSSGIFWDNDSLAALLALELKADLLILLSDVEGLYTGPPSDPNSKLIHTFVKEKHQ
DEITFGDKSRLGRGGMTAKVKAAVNAAYAGIPVIITSGYSAENIDKVLRGLRVGTLFHQD
ARLWAPITDSNARDMAVAARESSRKLQALSSEDRKKILLDIADALEANVTTIKAENELDV
ASAQEAGLEESMVARLVMTPGKISSLAASVRKLADMEDPIGRVLKKTEVADGLVLEKTSS
PLGVLLIVFESRPDALVQIASLAIRSGNGLLLKGGKEARRSNAILHKVITDAIPETVGGK
LIGLVTSREEIPDLLKLDDVIDLVIPRGSNKLVTQIKNTTKIPVLGHADGICHVYVDKAC
DTDMAKRIVSDAKLDYPAACNAMETLLVHKDLEQNAVLNELIFALQSNGVTLYGGPRASK
ILNIPEARSFNHEYCAKACTVEVVEDVYGAIDHIHRHGSAHTDCIVTEDHEVAELFLRQV
DSAAVFHNASTRFSDGFRFGLGAEVGVSTGRIHARGPVGVEGLLTTRWIMRGKGQVVDGD
NGIVYTHQDIPIQA*
>AT2G39800.2 | P5CS1 (DELTA1-PYRROLINE-5-CARBOXYLATE SYNTHASE 1) delta1-pyrroline-5-carboxylate synthetase
MAYYETMFDQLDVTAAQLLVNDSSFRDKDFRKQLNETVKSMLDLRVIPIFNENDAISTRR
APYQDSSGIFWDNDSLAALLALELKADLLILLSDVEGLYTGPPSDPNSKLIHTFVKEKHQ
DEITFGDKSRLGRGGMTAKVKAAVNAAYAGIPVIITSGYSAENIDKVLRGLRVGTLFHQD
ARLWAPITDSNARDMAVAARESSRKLQALSSEDRKKILLDIADALEANVTTIKAENELDV
ASAQEAGLEESMVARLVMTPGKISSLAASVRKLADMEDPIGRVLKKTEVADGLVLEKTSS
PLGVLLIVFESRPDALVQIASLAIRSGNGLLLKGGKEARRSNAILHKVITDAIPETVGGK
LIGLVTSREEIPDLLKLDDVIDLVIPRGSNKLVTQIKNTTKIPVLGHADGICHVYVDKAC
DTDMAKRIVSDAKLDYPAACNAMETLLVHKDLEQNAVLNELIFALQSNGVTLYGGPRASK
ILNIPEARSFNHEYCAKACTVEVVEDVYGAIDHIHRHGSAHTDCIVTEDHEVAELFLRQV
DSAAVFHNASTRFSDGFRFGLGAEVGVSTGRIHARGPVGVEGLLTTRWIMRGKGQVVDGD
NGIVYTHQDIPIQA*
>AT2G39800.1 | P5CS1 (DELTA1-PYRROLINE-5-CARBOXYLATE SYNTHASE 1) delta1-pyrroline-5-carboxylate synthetase
MEELDRSRAFARDVKRIVVKVGTAVVTGKGGRLALGRLGALCEQLAELNSDGFEVILVSS
GAVGLGRQRLRYRQLVNSSFADLQKPQTELDGKACAGVGQSSLMAYYETMFDQLDVTAAQ
LLVNDSSFRDKDFRKQLNETVKSMLDLRVIPIFNENDAISTRRAPYQDSSGIFWDNDSLA
ALLALELKADLLILLSDVEGLYTGPPSDPNSKLIHTFVKEKHQDEITFGDKSRLGRGGMT
AKVKAAVNAAYAGIPVIITSGYSAENIDKVLRGLRVGTLFHQDARLWAPITDSNARDMAV
AARESSRKLQALSSEDRKKILLDIADALEANVTTIKAENELDVASAQEAGLEESMVARLV
MTPGKISSLAASVRKLADMEDPIGRVLKKTEVADGLVLEKTSSPLGVLLIVFESRPDALV
QIASLAIRSGNGLLLKGGKEARRSNAILHKVITDAIPETVGGKLIGLVTSREEIPDLLKL
DDVIDLVIPRGSNKLVTQIKNTTKIPVLGHADGICHVYVDKACDTDMAKRIVSDAKLDYP
AACNAMETLLVHKDLEQNAVLNELIFALQSNGVTLYGGPRASKILNIPEARSFNHEYCAK
ACTVEVVEDVYGAIDHIHRHGSAHTDCIVTEDHEVAELFLRQVDSAAVFHNASTRFSDGF
RFGLGAEVGVSTGRIHARGPVGVEGLLTTRWIMRGKGQVVDGDNGIVYTHQDIPIQA*
>AT2G39800.1 | P5CS1 (DELTA1-PYRROLINE-5-CARBOXYLATE SYNTHASE 1) delta1-pyrroline-5-carboxylate synthetase
MEELDRSRAFARDVKRIVVKVGTAVVTGKGGRLALGRLGALCEQLAELNSDGFEVILVSS
GAVGLGRQRLRYRQLVNSSFADLQKPQTELDGKACAGVGQSSLMAYYETMFDQLDVTAAQ
LLVNDSSFRDKDFRKQLNETVKSMLDLRVIPIFNENDAISTRRAPYQDSSGIFWDNDSLA
ALLALELKADLLILLSDVEGLYTGPPSDPNSKLIHTFVKEKHQDEITFGDKSRLGRGGMT
AKVKAAVNAAYAGIPVIITSGYSAENIDKVLRGLRVGTLFHQDARLWAPITDSNARDMAV
AARESSRKLQALSSEDRKKILLDIADALEANVTTIKAENELDVASAQEAGLEESMVARLV
MTPGKISSLAASVRKLADMEDPIGRVLKKTEVADGLVLEKTSSPLGVLLIVFESRPDALV
QIASLAIRSGNGLLLKGGKEARRSNAILHKVITDAIPETVGGKLIGLVTSREEIPDLLKL
DDVIDLVIPRGSNKLVTQIKNTTKIPVLGHADGICHVYVDKACDTDMAKRIVSDAKLDYP
AACNAMETLLVHKDLEQNAVLNELIFALQSNGVTLYGGPRASKILNIPEARSFNHEYCAK
ACTVEVVEDVYGAIDHIHRHGSAHTDCIVTEDHEVAELFLRQVDSAAVFHNASTRFSDGF
RFGLGAEVGVSTGRIHARGPVGVEGLLTTRWIMRGKGQVVDGDNGIVYTHQDIPIQA*
>AT1G63130.1 | pentatricopeptide (PPR) repeat-containing protein
MRRLFAISSTGNRFVHRSLLGKGKCGTAPPSFSHCSFWVRDFSGVRYDYRKISINRLNDL
KLDDAVNLFGDMVKSRPFPSIVEFSKLLSAIAKMNKFDLVISLGEQMQNLGISHNLYTYS
ILINCFCRRSQLSLALAVLAKMMKLGYEPDIVTLNSLLNGFCHGNRISDAVSLVGQMVEM
GYQPDSFTFNTLIHGLFRHNRASEAVALVDRMVVKGCQPDLVTYGIVVNGLCKRGDIDLA
LSLLKKMEQGKIEPGVVIYNTIIDALCNYKNVNDALNLFTEMDNKGIRPNVVTYNSLIRC
LCNYGRWSDASRLLSDMIERKINPNVVTFSALIDAFVKEGKLVEAEKLYDEMIKRSIDPD
IFTYSSLINGFCMHDRLDEAKHMFELMISKDCFPNVVTYNTLIKGFCKAKRVDEGMELFR
EMSQRGLVGNTVTYTTLIHGFFQARECDNAQIVFKQMVSDGVLPDIMTYSILLDGLCNNG
KVETALVVFEYLQRSKMEPDIYTYNIMIEGMCKAGKVEDGWDLFCSLSLKGVKPNVVTYT
TMMSGFCRKGLKEEADALFREMKEEGPLPDSGTYNTLIRAHLRDGDKAASAELIREMRSC
RFVGDASTIGLVTNMLHDGRLDKSFLKMLS*
>AT2G01740.1 | pentatricopeptide (PPR) repeat-containing protein
MVREALQFLSRLRKSSNLPDPFTCNKHIHQLINSNCGILSLKFLAYLVSRGYTPHRSSFN
SVVSFVCKLGQVKFAEDIVHSMPRFGCEPDVISYNSLIDGHCRNGDIRSASLVLESLRAS
HGFICKPDIVSFNSLFNGFSKMKMLDEVFVYMGVMLKCCSPNVVTYSTWIDTFCKSGELQ
LALKSFHSMKRDALSPNVVTFTCLIDGYCKAGDLEVAVSLYKEMRRVRMSLNVVTYTALI
DGFCKKGEMQRAEEMYSRMVEDRVEPNSLVYTTIIDGFFQRGDSDNAMKFLAKMLNQGMR
LDITAYGVIISGLCGNGKLKEATEIVEDMEKSDLVPDMVIFTTMMNAYFKSGRMKAAVNM
YHKLIERGFEPDVVALSTMIDGIAKNGQLHEAIVYFCIEKANDVMYTVLIDALCKEGDFI
EVERLFSKISEAGLVPDKFMYTSWIAGLCKQGNLVDAFKLKTRMVQEGLLLDLLAYTTLI
YGLASKGLMVEARQVFDEMLNSGISPDSAVFDLLIRAYEKEGNMAAASDLLLDMQRRGLV
TAVSDADCSKQCGNEVNCS*
>AT1G33770.1 | protein kinase family protein
MGCICSKGAAEDEEGVVYHREKANEYWNKSSSVQLIAPLPSNKDDFSHKAVDGSSGGGRR
ASGLIVPIDDSHDGKTVIVERPSRSQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPY
WLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFANMDPE
SVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEP
QIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTS
RVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGS
PSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTL
LSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKRKKAEAVKWRGHESVRRGLRDSKV
TPEFIASGNSNVSLTTPSFKKEKRFTDTNSVIHPSSRSNVGEVKPSRSNNVPATMGDYLA
SSSQKENIVSRAPATTYMRKKNRMHYSGPLMPPGGNIEDMMKEHERRIQEAVRKSRLEKS
ATKKNKDISVKACA*
>AT5G63710.1 | leucine-rich repeat transmembrane protein kinase putative
MAHSGNGESFHDPLRGFIQRNCFRWNNQKLILQCFMALAFVGITSSTTQPDIEGGALLQL
RDSLNDSSNRLKWTRDFVSPCYSWSYVTCRGQSVVALNLASSGFTGTLSPAITKLKFLVT
LELQNNSLSGALPDSLGNMVNLQTLNLSVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSI
PTQFFSIPTFDFSGTQLICGKSLNQPCSSSSRLPVTSSKKKLRDITLTASCVASIILFLG
AMVMYHHHRVRRTKYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGF
GKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERI
LVYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAA
NILLDNNFEPVLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGI
TLLELVTGQRAIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNLTTYDSKEVETIVQV
ALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEE
TTVDQESIRLSTAR*
>AT2G32860.1 | BGLU33 (BETA GLUCOSIDASE 33) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MATATLTLFLGLLALTSTILSFNADARPQPSDEDLGTIIGPHQTSFDDEIGIVIGPHATV
DDEDIDMDMGTTVGPQTNLNDDDLGTIIGPEFEIHKQDFPADFIFGTSVSAYQVEGAKKG
SGRGLTSWDEFTHMFPEKVQQNGDGDEGVDFYTRYKDDIKLMKELNTNGFRFSISWTRIL
PYGTIKKGVNEEGVKFYNDLINELLANGIQPSVTLFHWESPLALEMEYGGFLNERIVEDF
REFANFCFKEFGDRVKNWATFNEPSVYSVAGYSKGKKAPGRCSKWQAPKCPTGDSSEEPY
IVAHNQILAHLAAVDEFRNCKKCQEGGGKIGIVLVSHWFEPKDPNSSEDVKAARRSLEYQ
LGWFLRPLTYGQYPAEMLEDVNIRLREFTPEESEKLRKSLDFVGLNYYGAFFSTPLAKVN
SSQLNYETDLRVNWTDSQNNSPHLKTTSMGIVIYPAGLKNILKHIKDEYMDPEIYIMENG
MDEIDYGTKNITEATNDYGRKEFIKSHILIMGKSIRMDKVRLKGYYIWSLMDNFEWDKGY
KVRFGLYYVDYNDNMKRYIRSSGKWLSEFLDSKETLHKCYFEGHREKGYAPKLFDVEYLE
PENSQLSYRSDFM*
>AT2G32860.1 | BGLU33 (BETA GLUCOSIDASE 33) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MATATLTLFLGLLALTSTILSFNADARPQPSDEDLGTIIGPHQTSFDDEIGIVIGPHATV
DDEDIDMDMGTTVGPQTNLNDDDLGTIIGPEFEIHKQDFPADFIFGTSVSAYQVEGAKKG
SGRGLTSWDEFTHMFPEKVQQNGDGDEGVDFYTRYKDDIKLMKELNTNGFRFSISWTRIL
PYGTIKKGVNEEGVKFYNDLINELLANGIQPSVTLFHWESPLALEMEYGGFLNERIVEDF
REFANFCFKEFGDRVKNWATFNEPSVYSVAGYSKGKKAPGRCSKWQAPKCPTGDSSEEPY
IVAHNQILAHLAAVDEFRNCKKCQEGGGKIGIVLVSHWFEPKDPNSSEDVKAARRSLEYQ
LGWFLRPLTYGQYPAEMLEDVNIRLREFTPEESEKLRKSLDFVGLNYYGAFFSTPLAKVN
SSQLNYETDLRVNWTDSQNNSPHLKTTSMGIVIYPAGLKNILKHIKDEYMDPEIYIMENG
MDEIDYGTKNITEATNDYGRKEFIKSHILIMGKSIRMDKVRLKGYYIWSLMDNFEWDKGY
KVRFGLYYVDYNDNMKRYIRSSGKWLSEFLDSKETLHKCYFEGHREKGYAPKLFDVEYLE
PENSQLSYRSDFM*
>AT2G32860.2 | BGLU33 (BETA GLUCOSIDASE 33) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MATATLTLFLGLLALTSTILSFNADARPQPSDEDLGTIIGPHQTSFDDEIGIVIGPHATV
DDEDIDMDMGTTVGPQTNLNDDDLGTIIGPEFEIHKQDFPADFIFGTSVSAYQVEGAKKG
SGRGLTSWDEFTHMFPEKVQQNGDGDEGVDFYTRYKDDIKLMKELNTNGFRFSISWTRIL
PYGTIKKGVNEEGVKFYNDLINELLANGIQPSVTLFHWESPLALEMEYGGFLNERIVEDF
REFANFCFKEFGDRVKNWATFNEPSVYSVAGYSKGKKAPGRCSKWQAPKCPTGDSSEEPY
IVAHNQILAHLAAVDEFRNCKKVEGGGKIGIVLVSHWFEPKDPNSSEDVKAARRSLEYQL
GWFLRPLTYGQYPAEMLEDVNIRLREFTPEESEKLRKSLDFVGLNYYGAFFSTPLAKVNS
SQLNYETDLRVNWTVITNNLSLPDLQTTSMGIVIYPAGLKNILKHIKDEYMDPEIYIMEN
GMDEIDYGTKNITEATNDYGRKEFIKSHILIMGKSIRMDKVRLKGYYIWSLMDNFEWDKG
YKVRFGLYYVDYNDNMKRYIRSSGKWLSEFLDSKETLHKCYFEGHREKGYAPKLFDVEYL
EPENSQLSYRSDFM*
>AT2G32860.2 | BGLU33 (BETA GLUCOSIDASE 33) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MATATLTLFLGLLALTSTILSFNADARPQPSDEDLGTIIGPHQTSFDDEIGIVIGPHATV
DDEDIDMDMGTTVGPQTNLNDDDLGTIIGPEFEIHKQDFPADFIFGTSVSAYQVEGAKKG
SGRGLTSWDEFTHMFPEKVQQNGDGDEGVDFYTRYKDDIKLMKELNTNGFRFSISWTRIL
PYGTIKKGVNEEGVKFYNDLINELLANGIQPSVTLFHWESPLALEMEYGGFLNERIVEDF
REFANFCFKEFGDRVKNWATFNEPSVYSVAGYSKGKKAPGRCSKWQAPKCPTGDSSEEPY
IVAHNQILAHLAAVDEFRNCKKVEGGGKIGIVLVSHWFEPKDPNSSEDVKAARRSLEYQL
GWFLRPLTYGQYPAEMLEDVNIRLREFTPEESEKLRKSLDFVGLNYYGAFFSTPLAKVNS
SQLNYETDLRVNWTVITNNLSLPDLQTTSMGIVIYPAGLKNILKHIKDEYMDPEIYIMEN
GMDEIDYGTKNITEATNDYGRKEFIKSHILIMGKSIRMDKVRLKGYYIWSLMDNFEWDKG
YKVRFGLYYVDYNDNMKRYIRSSGKWLSEFLDSKETLHKCYFEGHREKGYAPKLFDVEYL
EPENSQLSYRSDFM*
>AT5G24100.1 | leucine-rich repeat transmembrane protein kinase putative
MSRGRSFIFYFVLFLFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCT
TWPGVTCDIDGTRVTALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQL
KKLKAISLGNNRFSGPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNS
FSGEIPDLNLPGLRRLNFSNNNLTGSIPNSLKRFGNSAFSGNNLVFENAPPPAVVSFKEQ
KKNGIYISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSE
KEVSKLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVL
EDSKVIAVKRLKDIVVSRKDFKHQMEIVGNIKHENVAPLRAYVCSKEEKLMVYDYDSNGS
LSLRLHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQNLAHGNIKSSNVFMNSEGYGC
ISEAGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIM
DDRKEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPD
MVKVVETLEEIERD*
>AT5G45780.1 | leucine-rich repeat transmembrane protein kinase putative
MEISLMKFLFLGIWVYYYSVLDSVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGW
DINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIP
SELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFL
DLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNATGLSEKDNSKHHSLV
LSFAFGIVVAFIISLMFLFFWVLWHRSRLSRSHVQQDYEFEIGHLKRFSFREIQTATSNF
SPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTGEVQFQTEVEMIGLAVHRNLLRLF
GFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNP
KIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSS
EKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFD
DLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEGLVEQCEGGYEARAPSVSRNYSNGHEE
QSFIIEAIELSGPR*